Original Research
Accepted on 15 Aug 2025
European experience of patients with HER2-positive advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: the EUROPA T-DXd study
in Breast Cancer
Original Research
Accepted on 15 Aug 2025
in Breast Cancer
Case Report
Accepted on 15 Aug 2025
in Surgical Oncology
Original Research
Accepted on 15 Aug 2025
in Cancer Metabolism
Original Research
Accepted on 15 Aug 2025
in Gynecological Oncology
Original Research
Accepted on 15 Aug 2025
in Hematologic Malignancies
Review
Accepted on 15 Aug 2025
in Neuro-Oncology and Neurosurgical Oncology
Systematic Review
Accepted on 15 Aug 2025
in Gastrointestinal Cancers: Colorectal Cancer
Review
Published on 15 Aug 2025
in Molecular and Cellular Oncology
Review
Published on 15 Aug 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 15 Aug 2025
in Cancer Immunity and Immunotherapy
Case Report
Published on 15 Aug 2025
in Thoracic Oncology
Original Research
Published on 15 Aug 2025
in Genitourinary Oncology
Original Research
Published on 15 Aug 2025
in Breast Cancer
Case Report
Published on 15 Aug 2025
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Correction
Published on 15 Aug 2025
in Cancer Epidemiology and Prevention
Original Research
Published on 15 Aug 2025
in Thoracic Oncology